AHNAK mutations have been reported in other entities of neuroendocrine neoplasms (neuroblastomas and adrenocortical carcinomas, both with a frequency below 5%28), whereas BCOR mutations have been previously found in siNETs with a frequency of 5.6%29. This evidence concerns the gene AHNAK and adrenal cortex carcinoma.